News
have been released in posters at the 2024 European Hematology Association Hybrid Congress (EHA 2024), taking place in Madrid, Spain. Building on the data reported at the 2023 American Society of ...
The deal, which ChemGenex directors are recommending in the absence of a better offer, would hand Cephalon the Australian firm’s NDA-ready chronic myeloid leukemia (CML) candidate Omapro ...
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that updated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results